“What About the Implant, Doc?” Appraising Various Formulations of Buprenorphine
The Carlat Addiction Treatment Report, Volume 8, Number 5, July 2020
Edmund S. Higgins, MD.
Clinical Associate Professor of Psychiatry and Family Medicine, MUSC, Charleston, SC.
Dr. Higgins has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Buprenorphine can be administered via intravenous, transdermal, sublingual, buccal, and implanted formulations. We appraise the evidence for various formulations and suggest certain populations for which certain formulations may be a better choice.